Evidence map›Paper›PMID 32099756›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2020

Bioinspired Molecular Factories with Architecture and In Vivo Functionalities as Cell Mimics.

Tomaž Einfalt, Martina Garni, Dominik Witzigmann, Sandro Sieber, Niklaus Baltisberger, Jörg Huwyler, Wolfgang Meier, Cornelia G Palivan

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Programmable Enzymatic Reaction Network in Artificial Cell-Like Polymersomes.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  4. Review
  5. Article
  6. Article
  7. Light-Activated Membrane Transport in Polymeric Cell-Mimics.Angewandte Chemie (International ed. in English) · 2022
    Article
  8. Review
  9. Article
  10. Bioinspired Molecular Factories with Architecture and In Vivo Functionalities as Cell Mimics.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tomaž EinfaltDepartment of Chemistry University of Basel Mattenstrasse 24a, BPR 1096, P.O. Box 3350 CH-4002 Basel Switzerland.
Martina GarniDepartment of Chemistry University of Basel Mattenstrasse 24a, BPR 1096, P.O. Box 3350 CH-4002 Basel Switzerland.
Dominik WitzigmannDepartment of Pharmaceutical Sciences Division of Pharmaceutical Technology University of Basel Klingelbergstrasse 50 CH-4056 Basel Switzerland.
Sandro SieberDepartment of Pharmaceutical Sciences Division of Pharmaceutical Technology University of Basel Klingelbergstrasse 50 CH-4056 Basel Switzerland.
Niklaus BaltisbergerDepartment of Chemistry University of Basel Mattenstrasse 24a, BPR 1096, P.O. Box 3350 CH-4002 Basel Switzerland.
Jörg HuwylerDepartment of Pharmaceutical Sciences Division of Pharmaceutical Technology University of Basel Klingelbergstrasse 50 CH-4056 Basel Switzerland.
Wolfgang MeierDepartment of Chemistry University of Basel Mattenstrasse 24a, BPR 1096, P.O. Box 3350 CH-4002 Basel Switzerland.
Cornelia G PalivanDepartment of Chemistry University of Basel Mattenstrasse 24a, BPR 1096, P.O. Box 3350 CH-4002 Basel Switzerland.ORCID https://orcid.org/0000-0001-7777-5355

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite huge need in the medical domain and significant development efforts, artificial cells to date have limited composition and functionality. Although some artificial cells have proven successful for producing therapeutics or performing in vitro specific reactions, they have not been investigated in vivo to determine whether they preserve their architecture and functionality while avoiding toxicity. Here, these limitations are overcome and customizable cell mimic is achieved-molecular factories (MFs)-by supplementing giant plasma membrane vesicles derived from donor cells with nanometer-sized artificial organelles (AOs). MFs inherit the donor cell's natural cytoplasm and membrane, while the AOs house reactive components and provide cell-like architecture and functionality. It is demonstrated that reactions inside AOs take place in a close-to-nature environment due to the unprecedented level of complexity in the composition of the MFs. It is further demonstrated that in a zebrafish vertebrate animal model, these cell mimics show no apparent toxicity and retain their integrity and function. The unique advantages of highly varied composition, multicompartmentalized architecture, and preserved functionality in vivo open new biological avenues ranging from the study of biorelevant processes in robust cell-like environments to the production of specific bioactive compounds.

Indexed as

amphiphilic polymersartificial cellsenzymesmolecular factorypolymersomes

Identifiers

PMID32099756
PMCPMC7029636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.